Date | Programmes | Podcast Title | |
---|---|---|---|
16-Dec-21 |
Evening Edition (7:00 PM) |
RM1 Interbank Withdrawal Fees To Be Reinstated
Liew Ooi Hann, CEO, Ringgitplus |
|
05-Feb-20 |
Evening Edition (6:00 PM) |
Are ATM Charges Reasonable?
Lee Ching Wei, Chief Innovation Officer, iMoney |
|
23-May-19 |
Ringgit & Sense (9:30 AM) |
The End Of ATMs?
Hari Shivan, CEO, SoCash |
|
29-Nov-18 |
At The Movies (7:00 PM) |
Narcos: Mexico: A Conversation with Michael Peña and Eric Newman (Binge Watch #77)
Umapagan Ampikaipakan | Michael Peña | Eric Newman |
|
28-Nov-18 |
At The Movies (7:00 PM) |
Guang: A Conversation with Quek Shio Chuan and Ismail Kamarul (At the Movies #473)
Umapagan Ampikaipakan | Quek Shio Chuan | Ismail Kamarul |
|
27-Nov-18 |
At The Movies (7:00 PM) |
Robin Hood (At the Movies #472)
Umapagan Ampikaipakan | Iain McNally |
|
27-Nov-18 |
Enterprise Explores (12:00 PM) |
China’s cashless economy threatens to leave its elderly—and their money—behind
Richard Bradbury | Christine Wong | Arvindh Yuvaraj |
|
26-Nov-18 |
At The Movies (7:00 PM) |
Polis Evo 2: A Conversation with Joel Soh and Andre Chiew (At the Movies #471)
Umapagan Ampikaipakan | Joel Soh | Andre Chiew |
|
23-Nov-18 |
At The Movies (7:00 PM) |
The Bridge: A Conversation with Min Lim, Jason Chong, and Bront Palarae (Binge Watch #76)
Umapagan Ampikaipakan | Min Lim | Jason Chong | Bront Palarae |
|
22-Nov-18 |
At The Movies (7:00 PM) |
Ralph Breaks the Internet (At the Movies #470)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
21-Nov-18 |
At The Movies (7:00 PM) |
Narcos: Mexico (Binge Watch #75)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
19-Nov-18 |
At The Movies (7:00 PM) |
Mahaguru (At the Movies #469)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
16-Nov-18 |
At The Movies (7:00 PM) |
Fantastic Beasts: The Crimes Of Grindelwald (At the Movies #468)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
15-Nov-18 |
At The Movies (7:00 PM) |
The Kleptocrats (At the Movies #467)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
15-Nov-18 |
At The Movies (4:51 PM) |
Polis Evo 2 (At the Movies #466)
Umapagan Ampikaipakan | Iain McNally | Bahir Yeusuff |
|
14-Nov-18 |
At The Movies (7:00 PM) |
The Kleptocrats: A Conversation with Louise Story (At the Movies #465)
Umapagan Ampikaipakan | Louise Story |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Tech Talk
Breaking Up with Your Phone: The Case for a Digital Detox
Enterprise Explores
Inside Southeast Asia’s $19B Food Delivery Market
The Breakfast Grille Repeat
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we delve into the next stage of Malaysia's development, examining economic policy, structural challenges, and pathways for equitable growth.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
Talkback Thursday
BBC World Service